Bavarian Nordic A/S Return on Equity

Bavarian Nordic A/S (BVNRY) currently reports a ROE of 11.79%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Bavarian Nordic A/S's ROE history and peer comparisons.

Bavarian Nordic A/S's ROE of 11.79% is higher than the Healthcare sector average of -75.84%. That is roughly 115.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Bavarian Nordic A/S's current 11.79% should be judged against Healthcare norms (sector average: -75.84%) and against BVNRY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 11.79%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Bavarian Nordic A/S, and consider following BVNRY for alerts when major investors trade the stock.

Bavarian Nordic A/S is classified in the Healthcare sector. On ROE, it currently shows 11.79% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BVNRY with unrelated industries.